First tranche delivered, larger tranches en route: the same engine that just produced has visibly more already scheduled
The model's full reasoning — Q4 2023 call → NOWe need to determine if management describes one identifiable engine of new business with both: (1) a first tranche actually landed in the reported period, and (2) larger tranches already in motion behind it, with the remainder larger than what's been recognized. Look for specific examples. The transcript mentions Tyvaso DPI royalty and manufacturing, Afrezza, V-Go, MNKD-101, MNKD-201, etc. But we need an engine where a first tranche has landed and larger tranches are already committed/in motion. Consider Tyvaso DPI: They have royalty revenue and collaboration manufacturing. They sold 1% of royalty for $150M upfront. But that's a financing deal, not an engine of new business. The engine is Tyvaso DPI production and royalty. They report record revenue and production. But is there a larger tranche already in motion? They mention high-speed fill finish line qualification, PPQ, and expecting higher volumes. But that's about capacity expansion, not necessarily committed volumes. Also, they say "we are making as much as we can around the clock" and "nothing slowed down." But is there a specific contract or committed volumes? They have a collaboration with United Therapeutics. The royalty is based on sales. The continuation is based on demand, which is hoped-for? They mention TETON 1 and TETON 2 trials 70% enrolled, but that's for UT's trials, not directly a committed tranche for MannKind. The engine is ongoing production and royalty, but the first tranche is the current quarter's revenue, and the larger tranche is future quarters' revenue, but that's just ongoing business, not a specific new engine with a first tranche landed and larger tranches already in motion. It's routine business. Consider Afrezza: They have INHALE-3 and INHALE-1 trials. But those are clinical trials, not business engines. They are waiting for data. No first tranche landed. Consider MNKD-101 (clofazimine): They are about to file IND and start trial. No revenue yet. Consider MNKD-201: Phase 1 trial, no revenue. Consider V-Go: They purchased it, but it's existing product. What about the royalty sale? That's a financing transaction, not an engine of new business. Maybe the "high-speed fill finish line" is a new facility? They say "our team just this day completed the high-speed fill finish line in terms of qualification.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| ATAT | Atour Lifestyle Holdings Limited | Q1 2024 | 2024-05-23 | B+ |
| LINC | Lincoln Educational Services Corporation | Q1 2024 | 2024-05-06 | B+ |
| LTRX | Lantronix, Inc. | Q3 2024 | 2024-04-29 | C |
| E | Eni S.p.A. | Q1 2024 | 2024-04-24 | B+ |
| FRPH | FRP Holdings, Inc. | Q4 2023 | 2024-03-07 | C+ |
| ZLAB | Zai Lab Limited | Q4 2023 | 2024-02-28 | C |
| VMI | Valmont Industries, Inc. | Q4 2023 | 2024-02-22 | C |
| TBLA | Taboola.com Ltd. | Q3 2023 | 2023-11-08 | B+ |
| JLL | Jones Lang LaSalle Incorporated | Q3 2023 | 2023-11-02 | F |
| TEL | TE Connectivity Ltd. | Q4 2023 | 2023-11-01 | B |
| CLNE | Clean Energy Fuels Corp. | Q2 2023 | 2023-08-09 | C+ |
| LUCD | Lucid Diagnostics Inc. | Q1 2023 | 2023-05-16 | C+ |
| CEIX | CONSOL Energy Inc. | Q4 2022 | 2023-02-07 | B |
| ARE | Alexandria Real Estate Equities, Inc. | Q4 2022 | 2023-01-31 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| CDMO | Avid Bioservices, Inc. | Q3 2022 | 2022-03-08 | B+ |
| DG | Dollar General Corporation | Q2 2021 | 2021-08-26 | A |
| DOV | Dover Corporation | Q2 2021 | 2021-07-20 | B+ |
| MAS | Masco Corporation | Q3 2018 | 2018-10-30 | C |
| FEIM | Frequency Electronics, Inc. | Q1 2019 | 2018-09-13 | B+ |
| SRDX | Surmodics, Inc. | Q3 2018 | 2018-08-06 | A |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| MGA | Magna International Inc. | Q1 2018 | 2018-05-10 | B+ |
| SATS | EchoStar Corporation | Q1 2018 | 2018-05-10 | C+ |
| RACE | Ferrari N.V. | Q3 2017 | 2017-11-02 | C+ |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| HR | Healthcare Realty Trust Incorporated | Q1 2017 | 2017-05-08 | A |
| BDN | Brandywine Realty Trust | Q1 2017 | 2017-04-21 | C+ |
| WTS | Watts Water Technologies, Inc. | Q4 2016 | 2017-02-10 | B |
| PSX | Phillips 66 | Q4 2016 | 2017-02-03 | C+ |
| LBTYK | Liberty Global's | Q1 2016 | 2016-05-10 | C+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
| MTRX | Matrix Service Company | Q3 2016 | 2016-05-05 | D |
| CLF | Cleveland-Cliffs Inc. | Q1 2016 | 2016-04-29 | F |
| DD | DuPont de Nemours, Inc. | Q1 2016 | 2016-04-26 | B+ |
CDMO · Q3 2022 → YESThe question is about whether management describes ONE identifiable engine of new business that meets two criteria: NO The transcript describes the first phase of the Myford expansion as now operational and scheduling client projects, with management noting they are already utilizing the new space and that an extra $5 million is arguably in backlog attributable to it.
LINC · Q1 2024 → YESThe question is about whether management describes ONE identifiable engine of new business that meets two criteria: YES The transcript identifies the new-campus expansion strategy as the engine. East Point opened in Q1 with 29 starts and $90k revenue (first tranche, concrete and delivered).
LTRX · Q3 2024 → YESThe question is about whether management describes one identifiable engine of new business that meets two criteria: a first tranche has actually landed in the just-reported period, and larger tranches...